Stay updated on Enzalutamide Combo in Metastatic Prostate Cancer Clinical Trial
Sign up to get notified when there's something new on the Enzalutamide Combo in Metastatic Prostate Cancer Clinical Trial page.

Latest updates to the Enzalutamide Combo in Metastatic Prostate Cancer Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoChange DetectedAdded system revision v3.4.2 and removed the funding-status notice (v3.4.1); no changes to study data or core trial content. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.6%

- Check20 days agoChange DetectedA site-wide funding notice is now displayed and the page revision updated from v3.4.0 to v3.4.1.SummaryDifference0.6%

- Check28 days agoChange DetectedShow glossary option is added and highlights are introduced to indicate changes, with the revision tag updated from v3.3.4 to v3.4.0. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.8%

- Check42 days agoChange DetectedThe history now shows a new Revision: v3.3.4 and the removal of Revision: v3.3.3. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check63 days agoChange DetectedA new revision entry 'Revision: v3.3.3' was added, and the entries 'HHS Vulnerability Disclosure' and 'Revision: v3.3.2' were removed.SummaryDifference0.2%

- Check91 days agoChange DetectedRevision label updated from v3.2.0 to v3.3.2 on the page, with no visible changes to study history content or navigation. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

Stay in the know with updates to Enzalutamide Combo in Metastatic Prostate Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Enzalutamide Combo in Metastatic Prostate Cancer Clinical Trial page.